{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:18:01Z","timestamp":1782181081626,"version":"3.54.5"},"reference-count":8,"publisher":"SLACK, Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmic Surg Lasers Imaging Retina"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.3928\/23258160-20240523-01","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T14:36:28Z","timestamp":1718116588000},"page":"305-308","source":"Crossref","is-referenced-by-count":1,"title":["RWC Update: Removal of Subretinal Band Without Retinotomy; Geographic Atrophy: How Do You Select Appropriate Patients for Anti-Complement Therapy?; Shaken Baby Syndrome"],"prefix":"10.3928","volume":"55","author":[{"given":"Ashish","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihteh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Stanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eichenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Regillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwaljeet Harjot","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourous A.","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.11.4.11"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.07.011"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.08.027"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01520-9"},{"key":"e_1_3_3_5_2","article-title":"Treatment of geographic atrophy secondary to AMD with pegcetacoplan: two-year outcomes from the randomized phase 3 DERBY and OAKS trials","author":"Wykoff CC","unstructured":"Wykoff CC. Treatment of geographic atrophy secondary to AMD with pegcetacoplan: two-year outcomes from the randomized phase 3 DERBY and OAKS trials. Presented at the AAO Retina Subspecialty Day 2022. Accessed May 31, 2024. https:\/\/www.aao.org\/Assets\/b93442f7-3250-4d2c-8454-039d8ac0d74e\/637993592678870000\/retina-2022-syllabus-pdf?inline=1","journal-title":"Presented at the AAO Retina Subspecialty Day 2022"},{"key":"e_1_3_3_6_2","first-page":"S2468-6530(24)0","article-title":"Vision loss reduction with avacincaptad pegol for geographic atrophy: a 12-month post hoc analysis of the GATHER1 and GATHER2 trials","author":"Danzig CJ","year":"2024","unstructured":"Danzig CJ, Khanani AM, Kaiser PK, . Vision loss reduction with avacincaptad pegol for geographic atrophy: a 12-month post hoc analysis of the GATHER1 and GATHER2 trials. Ophthalmol Retina. 2024:S2468-6530(24)00224-0. PMID:38719191","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"e_1_3_3_7_2","first-page":"986","article-title":"Assessment of geographic atrophy (GA) lesion progression in the phase 3 OAKS and DERBY trials","volume":"64","author":"Chiang A","year":"2023","unstructured":"Chiang A, Bliss C, Ribeiro R. Assessment of geographic atrophy (GA) lesion progression in the phase 3 OAKS and DERBY trials. Invest. Ophthalmol. Vis. Sci. 2023;64(8):986.","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"e_1_3_3_8_2","article-title":"GATHER2 phase 3 efficacy results","author":"Khanani AM","unstructured":"Khanani AM, Patel SS, Staurenghi G, . GATHER2 phase 3 efficacy results. Presented at the AAO Retina Subspecialty Day 2022. Accessed May 31, 2023. https:\/\/www.aao.org\/Assets\/b93442f7-3250-4d2c-8454-039d8ac0d74e\/637993592678870000\/retina-2022-syllabus-pdf?inline=1","journal-title":"Presented at the AAO Retina Subspecialty Day 2022"}],"container-title":["Ophthalmic Surgery, Lasers and Imaging Retina"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T14:39:17Z","timestamp":1718116757000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/23258160-20240523-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.3928\/23258160-20240523-01"],"URL":"https:\/\/doi.org\/10.3928\/23258160-20240523-01","relation":{},"ISSN":["2325-8160","2325-8179"],"issn-type":[{"value":"2325-8160","type":"print"},{"value":"2325-8179","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}